PCSK9(His)-LDLR Binding Assay Kit

Only %1 left
Catalog #
78813
As low as $805 *

Cat # Size Price*

Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The PCSK9(His)-LDLR Binding Assay Kit is an ELISA-type 96-well format assay designed for screening and profiling purposes. Moreover, two pre-formulated assay buffers are supplied to validate PCSK9-LDLR binding affinity in either neutral or acidic binding conditions. The assay takes advantage of the high sensitivity of detection of His-tag PCSK9 by Anti-His HRP-antibody. First, the LDLR ectodomain is coated on a 96-well plate. Next, PCSK9 is incubated with LDLR on the plate. Finally, the plate is treated with Anti-His HRP-antibody followed by addition of an HRP substrate to produce chemiluminescence, measured using a chemiluminescence reader.

Figure 1: Illustration of the ELISA-based PCSK9(His)-LDLR Binding Assay Kit.

Need us to run inhibitor screens or profile your compounds against PCSK9(His)-LDLR? Check out our PCSK9 Screening Services.

Synonyms
Low-density lipoprotein receptor, LDL receptor, Proprotein convertase subtilisin/kexin type 9, Neural apoptosis-regulated convertase 1, NARC-1, Proprotein convertase 9, PC9, Subtilisin/kexin-like protease PC9, NARC1, PSEC0052
Product Info
Storage and Usage
Citations
Assay Kit Format
Chemiluminescent
Supplied As
The Assay Kit contains His-tag PCSK9, purified LDLR ectodomain and Anti-His-tag Horseradish Peroxidase (HRP)-conjugated antibody in sufficient amount for 100 binding reactions.
Materials Required But Not Supplied
  • PBS (Phosphate Buffer Saline)
  • Luminometer or microplate reader capable of reading chemiluminescence
  • Rotating or rocker platform
Format
Catalog # Name Amount Storage
71204 PCSK9(His)* 10 µg -80°C
71205 LDLR* 10 µg -80°C
  Anti-His HRP-D Antibody-D 10 µl -80°C
33298 3x PL-01 Assay Buffer 50 ml -20°C
79727 3x PL-02 Assay Buffer 50 ml -20°C
79728 Blocking Buffer 2 50 ml +4°C
79670 ELISA ECL Substrate A (translucent bottle) 6 ml Room Temp
ELISA ECL Substrate B (brown bottle) 6 ml Room Temp
79699 White 96-well microplate 1 Room Temp

*The concentration of the protein is lot-specific and will be indicated on the tube.

UniProt #
PCSK9: Q8NBP7; LDLR: P01130
Background

PCSK9 (Proprotein convertase subtilisin/kexin type 9) functions as a negative regulator of hepatic low-density lipoprotein receptors (LDLRs) and therefore is a critical regulator of cholesterol metabolism. It is an endopeptidase that binds to the EGFR-like ectodomain of LDLR, leading to LDLR degradation, which in turn, results in increased circulating LDL. Inhibiting the PCSK9-LDLR interaction is an increasingly desirable therapeutic approach for lowering LDL-cholesterol levels to replace or supplement statins. New therapies are critical for addressing atherosclerosis, stroke, heart disease, and other cardiovascular disorders.